New Blood Biomarker for Predicting Dementia Before Symptoms Develop
Measuring blood levels of P-tau181 may allow doctors to diagnose Alzheimer’s before the onset of symptoms. Elevated levels of P-tau181 in the blood were associated with greater amyloid-beta accumulation in the brain and outperformed two other biomarkers in predicting signs of amyloid-beta in brain scans.
Comments